Intiva BioPharma
Glendale, US · Delaware corporation
Founders & leadership
AB
Alain BankierNamed on SEC filing
RG
Robert GoldfarbNamed on SEC filing
JF
Jeffrey FriedlandNamed on SEC filing
RG
Richard GreenbergNamed on SEC filing
EW
Evan WasoffNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 2 rounds · 2017
▶$45.2KraisedDec 2017 · 2 investors · PharmaceuticalsRule 506(b)
▶$45.2KraisedDec 2017 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey FriedlandExecutive Officer, Director
- Alain BankierDirector
- Richard GreenbergExecutive Officer, Director
- Evan WasoffExecutive Officer
- Robert GoldfarbExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $45.2K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedDec 2017 · 69 investors · PharmaceuticalsRule 506(b)
▶$1.4MraisedDec 2017 · 69 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alain BankierDirector
- Robert GoldfarbExecutive Officer
- Jeffrey FriedlandExecutive Officer, Director
- Richard GreenbergExecutive Officer, Director
- Evan WasoffExecutive Officer
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Intiva BioPharma raised?
- Intiva BioPharma has disclosed $1.4M raised across 2 rounds.
- Where is Intiva BioPharma headquartered?
- Intiva BioPharma is headquartered in Glendale, US.